{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:23:50Z","timestamp":1718929430413},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,20]]},"DOI":"10.7759\/cureus.62757","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:29:12Z","timestamp":1718890152000},"source":"Crossref","is-referenced-by-count":0,"title":["Dapagliflozin-Induced Acute Pancreatitis: A Case Presentation and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Panagiota","family":"Issa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Agapakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina","family":"Machaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karageorgiou","family":"Ioannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Kotronis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2015.12.006","article-title":"Severe acute pancreatitis and necrotizing pancreatitis","volume":"32","author":"Maheshwari R","year":"2016","unstructured":"Maheshwari R, Subramanian RM. Severe acute pancreatitis and necrotizing pancreatitis. Crit Care Clin. 2016, 32:279-90. 10.1016\/j.ccc.2015.12.006","journal-title":"Crit Care Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.218","article-title":"American College of Gastroenterology guideline: management of acute pancreatitis","volume":"108","author":"Tenner S","year":"2013","unstructured":"Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013, 108:1400-15; 1416. 10.1038\/ajg.2013.218","journal-title":"Am J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.6.649","article-title":"Epidemiology of alcohol-related liver and pancreatic disease in the United States","volume":"168","author":"Yang AL","year":"2008","unstructured":"Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008, 168:649-56. 10.1001\/archinte.168.6.649","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2010.02.002","article-title":"Drug induced pancreatitis","volume":"24","author":"Nitsche CJ","year":"2010","unstructured":"Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010, 24:143-55. 10.1016\/j.bpg.2010.02.002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2983","article-title":"Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study","volume":"38","author":"Thomsen RW","year":"2015","unstructured":"Thomsen RW, Pedersen L, M\u00f8ller N, Kahlert J, Beck-Nielsen H, S\u00f8rensen HT. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study. Diabetes Care. 2015, 38:1089-98. 10.2337\/dc13-2983","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13650","article-title":"A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors","volume":"21","author":"Brown E","year":"2019","unstructured":"Brown E, Rajeev SP, Cuthbertson DJ, Wilding JP. A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors. Diabetes Obes Metab. 2019, 21:9-18. 10.1111\/dom.13650","journal-title":"Diabetes Obes Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024","volume":"47","year":"2024","unstructured":"9. Pharmacologic approaches to glycemic treatment. standards of care in diabetes-2024. Diabetes Care. 2024, 47:S158-78. 10.2337\/dc24-S009","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S86641","article-title":"Canagliflozin-induced pancreatitis: a rare side effect of a new drug","volume":"11","author":"Chowdhary M","year":"2015","unstructured":"Chowdhary M, Kabbani AA, Chhabra A. Canagliflozin-induced pancreatitis: a rare side effect of a new drug. Ther Clin Risk Manag. 2015, 11:991-4. 10.2147\/TCRM.S86641","journal-title":"Ther Clin Risk Manag"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0976-0105.160753","article-title":"Acute pancreatitis in the use of canagliflozin: a rare side-effect of the novel therapy for type 2 diabetes mellitus","volume":"6","author":"Srivali N","year":"2015","unstructured":"Srivali N, Thongprayoon C, Cheungpasitporn W, Ungprasert P. Acute pancreatitis in the use of canagliflozin: a rare side-effect of the novel therapy for type 2 diabetes mellitus. J Basic Clin Pharm. 2015, 6:101-2. 10.4103\/0976-0105.160753","journal-title":"J Basic Clin Pharm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000135","article-title":"Canagliflozin-associated acute pancreatitis","volume":"23","author":"Verma R","year":"2016","unstructured":"Verma R. Canagliflozin-associated acute pancreatitis. Am J Ther. 2016, 23:e972-3. 10.1097\/MJT.0000000000000135","journal-title":"Am J Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000561","article-title":"Drug-induced necrotizing pancreatitis with a focus on canagliflozin","volume":"24","author":"Patel KM","year":"2017","unstructured":"Patel KM, Pikas E, George T. Drug-induced necrotizing pancreatitis with a focus on canagliflozin. Am J Ther. 2017, 24:e496. 10.1097\/MJT.0000000000000561","journal-title":"Am J Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018786716","article-title":"Empagliflozin-induced pancreatitis","volume":"52","author":"McIntire DR","year":"2018","unstructured":"McIntire DR, Bayne DB. Empagliflozin-induced pancreatitis. Ann Pharmacother. 2018, 52:1158-9. 10.1177\/1060028018786716","journal-title":"Ann Pharmacother"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.5530\/ijmedph.2018.1.10","article-title":"Dapagliflozin induced pancreatitis","volume":"8","author":"Gutch M","year":"2018","unstructured":"Gutch M, Bhattacharya A, Kumar S, et al.. Dapagliflozin induced pancreatitis. Int J Med Public Health. 2018, 8:45-7.","journal-title":"Int J Med Public Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6724504","article-title":"Dapagliflozin-induced acute pancreatitis: a case report and review of literature","volume":"2020","author":"Sujanani SM","year":"2020","unstructured":"Sujanani SM, Elfishawi MM, Zarghamravanbaksh P, Castillo FJ, Reich DM. Dapagliflozin-induced acute pancreatitis: a case report and review of literature. Case Rep Endocrinol. 2020, 2020:6724504. 10.1155\/2020\/6724504","journal-title":"Case Rep Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12325","article-title":"Adverse side effects: empagliflozin-related acute pancreatitis case report","volume":"12","author":"Zeidan BS Jr","year":"2020","unstructured":"Zeidan BS Jr, Boadu C, Hernandez A, Frunzi J, Adetula I. Adverse side effects: empagliflozin-related acute pancreatitis case report. Cureus. 2020, 12:e12325. 10.7759\/cureus.12325","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/ds21-0025","article-title":"Probable dapagliflozin-associated acute pancreatitis","volume":"35","author":"Barrett AD","year":"2022","unstructured":"Barrett AD, Pitts MA, Myers EM, Johnson JL. Probable dapagliflozin-associated acute pancreatitis. Diabetes Spectr. 2022, 35:232-8. 10.2337\/ds21-0025","journal-title":"Diabetes Spectr"},{"key":"ref17","unstructured":"April - June 2016 | potential signals of serious risks\/new safety information identified by the FDA Adverse Event Reporting System (FAERS). (2024). Accessed. August 5, 2024: https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/april-june-2016-potential-s...."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.977582","article-title":"Analysis of acute pancreatitis associated with SGLT-2 inhibitors and predictive factors of the death risk: based on food and drug administration adverse event report system database","volume":"13","author":"Zhang L","year":"2022","unstructured":"Zhang L, Mao W, Li X, Wang X, Liu J, Hu S, Hu J. Analysis of acute pancreatitis associated with SGLT-2 inhibitors and predictive factors of the death risk: based on food and drug administration adverse event report system database. Front Pharmacol. 2022, 13:977582. 10.3389\/fphar.2022.977582","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v5.i4.405","article-title":"Contemporary review of drug-induced pancreatitis: a different perspective","volume":"5","author":"Hung WY","year":"2014","unstructured":"Hung WY, Abreu Lanfranco O. Contemporary review of drug-induced pancreatitis: a different perspective. World J Gastrointest Pathophysiol. 2014, 5:405-15. 10.4291\/wjgp.v5.i4.405","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5313","article-title":"An investigation on the association between sodium glucose co-transporter 2 inhibitors use and acute pancreatitis: a VigiBase study","volume":"30","author":"Frent I","year":"2021","unstructured":"Frent I, Bucsa C, Leucuta D, Farcas A, Mogosan C. An investigation on the association between sodium glucose co-transporter 2 inhibitors use and acute pancreatitis: a VigiBase study. Pharmacoepidemiol Drug Saf. 2021, 30:1428-40. 10.1002\/pds.5313","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256429-dapagliflozin-induced-acute-pancreatitis-a-case-presentation-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:29:16Z","timestamp":1718890156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256429-dapagliflozin-induced-acute-pancreatitis-a-case-presentation-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.62757","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}